AI Summary & Key Takeaways
AI InsightCVVHDF treatment was started because of anuria and metabolic acidosis.Patient who underwent CVVHDF treatment for 12-days transferred to nephrology service on the 23rd day of the ICU admission withfull consciousness and stabilized vitals.In conclusion, hemodialysis and CVVHDF should be the first treatment methods to be considered in patients with metforminassociatedlactic acidosis.
📌 3 Key Takeaways
Özet
Metformin is a biguanide group drug commonly used in the treatment of Type 2 DM. Even though Metformin- Associated LacticAcidosis (MALA) is not seen very frequently, MALA has a high mortality rate. This case is presented to draw attention to efficiencyof hemodialysis and CVVHDF tin the treatment of MALA.A 25-year-old female patient was brought to the emergency service with abdominal pain and confusion. In her detailed history,it was learned that she took 100 tablets of metformin (1000 mg per tablet). Hemodialysis initiated because of severe metabolicacidosis, elevation of blood urea and hyperkalemia were seen in laboratory results. After that, patient was intubated because of lowGlasgow Coma Scale (GCS:3) and vasopressor agent were started due to hypotension. In the intensive care unit, blood glucose wasseen 44 mg dl-1 and treated with 10% dextrose solution. CVVHDF treatment was started because of anuria and metabolic acidosis.Patient who underwent CVVHDF treatment for 12-days transferred to nephrology service on the 23rd day of the ICU admission withfull consciousness and stabilized vitals.In conclusion, hemodialysis and CVVHDF should be the first treatment methods to be considered in patients with metforminassociatedlactic acidosis. Renal replacement therapies, initiated rapidly and maintained for an adequate time period are promisingin this high mortality rate cases.